mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
5e-05 |
mRNA |
CAY10618 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
6e-05 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
6e-05 |
mRNA |
GSK461364 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
6e-05 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
6e-05 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
7e-05 |
mRNA |
SID 26681509 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
8e-05 |
mRNA |
MST-312 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0001 |
mRNA |
SN-38 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0001 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0002 |